Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S Herbert

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Virology Journal|April 28, 2009
Incorporation of membrane-bound, mammalian-derived immunomodulatory proteins into influenza whole virus vaccines boosts immunogenicity and protection against lethal challengeAndrew S Herbert, Lynn Heffron, Roy Sundick, et al.
Viruses|December 4, 2012
Niemann-Pick C1 (NPC1)/NPC1-like1 chimeras define sequences critical for NPC1's function as a flovirus entry receptorAnuja Krishnan, Emily Happy Miller, Andrew S Herbert, et al.
Science (New York, N.Y.)|August 6, 2020
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2Kui K Chan, Danielle Dorosky, Preeti Sharma, et al.
International Journal of Biological Macromolecules|April 29, 2021
Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacyYash Gupta, Dawid Maciorowski, Samantha E Zak, et al.
ACS Infectious Diseases|June 28, 2016
Cysteine Cathepsin Inhibitors as Anti-Ebola AgentsWouter A van der Linden, Christopher J Schulze, Andrew S Herbert, et al.
Nature Communications|September 16, 2024
Longitudinal proteome-wide antibody profiling in Marburg virus survivors identifies wing domain immunogen for vaccine designSurender Khurana, Gabrielle Grubbs, Supriya Ravichandran, et al.
RSC Medicinal Chemistry|November 15, 2021
A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU/NSP15): <i>in silico</i> and <i>in vitro</i> investigationsSumit Kumar, Yash Gupta, Samantha E Zak, et al.
The Journal of Infectious Diseases|August 27, 2021
Characterization of an Anti-Ebola Virus Hyperimmune Globulin Derived From Convalescent PlasmaJonathan M Ciencewicki, Andrew S Herbert, Nadia Storm, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2012
Postexposure antibody prophylaxis protects nonhuman primates from filovirus diseaseJohn M Dye, Andrew S Herbert, Ana I Kuehne, et al.
Scientific Reports|July 23, 2024
Inflammation in the COVID-19 airway is due to inhibition of CFTR signaling by the SARS-CoV-2 spike proteinHung Caohuy, Ofer Eidelman, Tinghua Chen, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Virology Journal|April 28, 2009
Incorporation of membrane-bound, mammalian-derived immunomodulatory proteins into influenza whole virus vaccines boosts immunogenicity and protection against lethal challengeAndrew S Herbert, Lynn Heffron, Roy Sundick, et al.
Viruses|December 4, 2012
Niemann-Pick C1 (NPC1)/NPC1-like1 chimeras define sequences critical for NPC1's function as a flovirus entry receptorAnuja Krishnan, Emily Happy Miller, Andrew S Herbert, et al.
Science (New York, N.Y.)|August 6, 2020
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2Kui K Chan, Danielle Dorosky, Preeti Sharma, et al.
International Journal of Biological Macromolecules|April 29, 2021
Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacyYash Gupta, Dawid Maciorowski, Samantha E Zak, et al.
ACS Infectious Diseases|June 28, 2016
Cysteine Cathepsin Inhibitors as Anti-Ebola AgentsWouter A van der Linden, Christopher J Schulze, Andrew S Herbert, et al.
Nature Communications|September 16, 2024
Longitudinal proteome-wide antibody profiling in Marburg virus survivors identifies wing domain immunogen for vaccine designSurender Khurana, Gabrielle Grubbs, Supriya Ravichandran, et al.
RSC Medicinal Chemistry|November 15, 2021
A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU/NSP15): <i>in silico</i> and <i>in vitro</i> investigationsSumit Kumar, Yash Gupta, Samantha E Zak, et al.
The Journal of Infectious Diseases|August 27, 2021
Characterization of an Anti-Ebola Virus Hyperimmune Globulin Derived From Convalescent PlasmaJonathan M Ciencewicki, Andrew S Herbert, Nadia Storm, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2012
Postexposure antibody prophylaxis protects nonhuman primates from filovirus diseaseJohn M Dye, Andrew S Herbert, Ana I Kuehne, et al.
Scientific Reports|July 23, 2024
Inflammation in the COVID-19 airway is due to inhibition of CFTR signaling by the SARS-CoV-2 spike proteinHung Caohuy, Ofer Eidelman, Tinghua Chen, et al.
Pageof 9